Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Zingmet-G1 Tablet

Prescription Icon
Prescription Required

Marketer

Inolife Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Zingmet-G1 Tablet

GlucoBalance Duo tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. GlucoBalance Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney impairment, vision loss, neuropathy, and limb damage. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and appropriate management strategies. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor of any history of heart disease before starting GlucoBalance Duo; it may be unsuitable. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring is necessary, and your physician may recommend blood tests to track blood cell counts and liver function.

Uses of Zingmet-G1 Tablet

Managing Type 2 Diabetes

Major Benefits of Zingmet-G1 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Zingmet-G1 Tablet with a meal.

Common Side effects of Zingmet-G1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Zingmet-G1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Zingmet-G1 Tablet with a meal.

How Zingmet-G1 Tablet works:

Glimepiride and Metformin, the active components of Zingmet-G1 Tablet, act synergistically to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zingmet-G1 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zingmet-G1 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Zingmet-G1 Tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Zingmet-G1 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Zingmet-G1 Tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Zingmet-G1 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A low starting dose is generally advised for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Zingmet-G1 Tablet :

Should you forget a Zingmet-G1 Tablet dose, ingest it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zingmet-G1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zingmet-G1 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zingmet-G1 Tablet use can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Zingmet-G1 and seek immediate medical attention.
Zingmet-G1 tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Zingmet-G1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Zingmet-G1 Tablet use can lead to Vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Yes, Zingmet-G1 Tablets can lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Zingmet-G1 Tablet and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Zingmet-G1 Tablet
112
MRP 130
13% off